Sox21 inhibits glioma progression in vivo by forming complexes with Sox2 and stimulating aberrant differentiation

International Journal of Cancer

Volumn 133, Issue 6, 2013, Pages 1345-1356

  Caglayan, Demet ^a   Lundin, Erika ^a   Kastemar, Marianne ^a   Westermark, Bengt ^a   Ferletta, Maria ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

brain tumors; glioma; S100; Sox2; Sox21

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; DOXYCYCLINE; TETRACYCLINE; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SOX21; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMPLEX FORMATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME REGULATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TUMOR VOLUME;

BRAIN TUMORS; GLIOMA; S100; SOX2; SOX21;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; GLIOMA; HUMANS; MICE; NERVE GROWTH FACTORS; PROTEIN BINDING; S100 PROTEINS; SOXB1 TRANSCRIPTION FACTORS; SOXB2 TRANSCRIPTION FACTORS;

EID: 84879992279     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28147     Document Type: Article

References (45)

1. Aldape K, Antonescu C, Becker A, et al. WHO classification of tumours of the central nervous system, 4th edn. Lyon, France: International Agency for Research on Cancer, 2007.
2. Ohgaki H, Dessen P, Jourde B, et al. Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004; 64: 6892-9.
3. Harris MA, Yang H, Low BE, et al. Cancer stem cells are enriched in the side population cells in a mouse model of glioma. Cancer Res 2008; 68: 10051-9.
4. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
5. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
6. Gubbay J, Collignon J, Koopman P, et al. A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes. Nature 1990; 346: 245-50.
7. Wegner M,. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res 1999; 27: 1409-20.
8. Uchikawa M, Kamachi Y, Kondoh H,. Two distinct subgroups of Group B Sox genes for transcriptional activators and repressors: their expression during embryonic organogenesis of the chicken. Mech Dev 1999; 84: 103-20.
9. Ferletta M, Caglayan D, Mokvist L, et al. Forced expression of Sox21 inhibits Sox2 and induces apoptosis in human glioma cells. Int J Cancer 2011; 129: 45-60.
10. Guth SI, Wegner M,. Having it both ways: Sox protein function between conservation and innovation. Cell Mol Life Sci 2008; 65: 3000-18.
11. Ellis P, Fagan BM, Magness ST, et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Dev Neurosci 2004; 26: 148-65.
12. Ferri AL, Cavallaro M, Braida D, et al. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 2004; 131: 3805-19.
13. Kondo T, Raff M,. Chromatin remodeling and histone modification in the conversion of oligodendrocyte precursors to neural stem cells. Genes Dev 2004; 18: 2963-72.
14. Bylund M, Andersson E, Novitch BG, et al. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Nat Neurosci 2003; 6: 1162-8.
15. Sandberg M, Kallstrom M, Muhr J,. Sox21 promotes the progression of vertebrate neurogenesis. Nat Neurosci 2005; 8: 995-1001.
16. Mallanna SK, Ormsbee BD, Iacovino M, et al. Proteomic analysis of Sox2-associated proteins during early stages of mouse embryonic stem cell differentiation identifies Sox21 as a novel regulator of stem cell fate. Stem Cells 2010; 28: 1715-27.
17. Alonso MM, Diez-Valle R, Manterola L, et al. Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas. PLoS One 2011; 6: e26740.
18. Bass AJ, Watanabe H, Mermel CH, et al. SOX2 is an amplified lineage-survival oncogene in lung and esophageal squamous cell carcinomas. Nat Genet 2009; 41: 1238-42.
19. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
20. Fang X, Yu W, Li L, et al. ChIP-seq and functional analysis of the SOX2 gene in colorectal cancers. OMICS 2010; 14: 369-84.
21. Enblad P, Hesselager G, Bongcam-Rudloff E, et al. Modulation of phenotype and induction of irregular vessels accompany high tumorigenic potential of clonal human glioma cells xenografted to nude-rat brain. Int J Cancer 2000; 85: 819-28.
22. Cheray M, Petit D, Forestier L, et al. Glycosylation-related gene expression is linked to differentiation status in glioblastomas undifferentiated cells. Cancer Lett 2011; 312: 24-32.
23. Savary K, Caglayan D, Caja L, et al. Snail depletes the tumorigenic potential of glioblastoma. Oncogene, in press.
24. Pollard SM, Yoshikawa K, Clarke ID, et al. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 2009; 4: 568-80.
25. Carpenter AE, Jones TR, Lamprecht MR, et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 2006; 7: R100.
26. Galderisi U, Cipollaro M, Giordano A,. Stem cells and brain cancer. Cell Death Differ 2006; 13: 5-11.
27. Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006; 5: 67.
28. Soderberg O, Gullberg M, Jarvius M, et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 2006; 3: 995-1000.
29. Juan G, Traganos F, James WM, et al. Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis. Cytometry 1998; 32: 71-7.
30. The Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008; 455: 1061-8.
31. Hagerstrand D, He X, Bradic Lindh M, et al. Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile. Neuro Oncol 2011; 13: 1178-91.
32. Lee J, Kotliarova S, Kotliarov Y, et al. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9: 391-403.
33. Eschbacher JM, Yeh R-F, Smirnov I, et al. Sox2: a glioma specific marker and a potential target for therapy. FASEB J 2008; 22: 706.18 (meeting abstract).
34. Phi JH, Park SH, Kim SK, et al. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway. Am J Surg Pathol 2008; 32: 103-12.
35. Ferletta M,. The role of Sox transcription factors in brain tumorigenesis. Molecular targets of CNS tumors. ed. Rijeka: InTech, 2011. 97-124.
36. Gangemi RM, Griffero F, Marubbi D, et al. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 2009; 27: 40-8.
37. Ge Y, Zhou F, Chen H, et al. Sox2 is translationally activated by eukaryotic initiation factor 4E in human glioma-initiating cells. Biochem Biophys Res Commun 2010; 397: 711-7.
38. Wan F, Herold-Mende C, Campos B, et al. Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers 2011; 16: 136-43.
39. Holmberg J, He X, Peredo I, et al. Activation of neural and pluripotent stem cell signatures correlates with increased malignancy in human glioma. PLoS One 2011; 6: e18454.
40. Kuzmichev AN, Kim SK, D'Alessio AC, et al. Sox2 acts through Sox21 to regulate transcription in pluripotent and differentiated cells. Curr Biol 2012; 22: 1705-10.
41. Chakravarthy H, Ormsbee BD, Mallanna SK, et al. Rapid activation of the bivalent gene Sox21 requires displacement of multiple layers of gene-silencing machinery. FASEB J 2011; 25: 206-18.
42. Cox JL, Wilder PJ, Desler M, et al. Elevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells. PLoS One 2012; 7: e44087.
43. Kamachi Y, Uchikawa M, Kondoh H,. Pairing SOX off: with partners in the regulation of embryonic development. Trends Genet 2000; 16: 182-7.
44. Miyagi S, Saito T, Mizutani K, et al. The Sox-2 regulatory regions display their activities in two distinct types of multipotent stem cells. Mol Cell Biol 2004; 24: 4207-20.
45. Tomioka M, Nishimoto M, Miyagi S, et al. Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex. Nucleic Acids Res 2002; 30: 3202-13.